BIO Releases Statement on Ethanol Initiative; Video AvailableJan 31 2006
WASHINGTON, D.C. (January 31, 2006) – Brent Erickson, executive vice president of the Biotechnology Industry Organization’s Industrial & Environmental Section, released the following... |
|
BIO President Jim Greenwood Applauds President's Initiatives in State of the Union AddressJan 31 2006
WASHINGTON, D.C. (January 31, 2006) -- Jim Greenwood, president of the Biotechnology Industry Organization (BIO), applauded the President for the initiatives outlined in his State of... |
|
BIO 2006 Media RegistrationJan 30 2006
From: Dan Eramian
Re: BIO 2006
Date: January 30, 2006 _____________________________________________________... |
|
Promises in Stem Cell Research a Focal Point at BIO 2006Jan 24 2006
WASHINGTON, D.C. (January 24, 2006) --The business, science, and regulatory aspects of stem cell research and regenerative medicine will be a focal point at the Biotechnology Industry Organization... |
|
Merck’s Peter S. Kim to Deliver Keynote Address at BIO CEO and Investor ConferenceJan 23 2006
WASHINGTON, D.C. (January 23, 2006) -- Peter S. Kim, President of Merck Research Laboratories, will be delivering the luncheon keynote address at the 8th annual CEO and Investor... |
|
BIO CEOs to Testify on IRS Stock Option RegulationsJan 23 2006
WASHINGTON, D.C. (January 23, 2006) – Gary McGarrity, president and CEO of Intronn, and Lawrence Tamarkin, president and CEO of CytImmune Sciences Inc., will testify on behalf of the... |
|
Asian, U.S., European Biotech and Drug Companies to Partner at BIO Conference in TokyoJan 19 2006
WASHINGTON, D.C. (January 19, 2006) – The Biotechnology Industry Organization (BIO) will sponsor its third annual BIO-Asia Partnering Conference Jan. 30-31, 2006, in Tokyo at the Grand Hyatt... |
|
BIO Statement on Korean Scientist Hwang Woo-sukJan 18 2006
WASHINGTON, D.C. (January 18, 2006) -- Jim Greenwood, president of the Biotechnology Industry Organization (BIO), issued the following statement on the discredited research of Korean... |
|
Biotechnology Industry Ends 2005 with Breakthrough Product Approvals and Steady FinancingJan 18 2006
WASHINGTON, D.C. (January 18, 2006) – The biotechnology industry ended 2005 with steady financial investments and product deliveries as companies succeeded in introducing novel therapies for... |
|
BIO and 21 Patient Groups Issue Letter Supporting FDA’s Critical Path InitiativeJan 13 2006
... |
